Abstract
Correction to: Oncogenehttps://doi.org/10.1038/s41388-018-0238-8, published online 17 April 2018 Following the publication of this article, the authors noted two inadvertent errors in Figure 5c, which occurred during figure assembly. The JAK2 immunoblot was mistakenly used in place of the STAT5 immunoblot, and the GAPDH loading control was inadvertently taken from a different blot generated from the same cell lysates. The corrected Figure 5c is provided below. The authors confirm these errors do not affect the underlying experimental data or the conclusions of the study and apologise for any inconvenience caused by these errors. Figure 5 (Figure presented.).
| Original language | English |
|---|---|
| Pages (from-to) | 2072-2073 |
| Number of pages | 2 |
| Journal | Oncogene |
| Volume | 45 |
| Issue number | 21 |
| DOIs |
|
| State | Published - 11 Jun 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance (Oncogene, (2018), 37, 29, (3981-3997), 10.1038/s41388-018-0238-8)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver